Study Stopped
study abandoned
Endoscopic Characteristics of Colonic Tumours
C-LST
A Correlation of the Endoscopic Characteristics of Colonic LSTs With Their Somatic or Germline Mutations. A Prospective, Genome Wide Study
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The purpose is to investigate whether polyps that look different at colonoscopy, have formed via different mutations and have different risks of turning into cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jun 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 9, 2011
CompletedFirst Posted
Study publicly available on registry
June 14, 2011
CompletedStudy Start
First participant enrolled
June 3, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 3, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 3, 2019
CompletedMarch 27, 2025
March 1, 2025
Same day
June 9, 2011
March 25, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Significant differences in molecular abnormalities.
The aim of this project is to look for statistically significant differences in molecular abnormalities from the three known genetic pathways, between the two different morphological types, granular and non-granular, to potentially demonstrate that these different polyps form via different genetic pathways.
Samples will be looked at and stored for approx 15 years
Study Arms (1)
Tissue sample
OTHERPatients who consent to participate in this study will have a small sample of their polyp and normal tissue sent for molecular testing.
Interventions
A small sample of the colonic polyp will be obtained for molecular testing. The remaining polyp will be sent for regular histological testing
Eligibility Criteria
You may qualify if:
- Intention to perform Endoscopic Mucosal Resection
- Polyp equal to or greater than 20mm
- over 18 years of age
- Able to give informed consent to involvement in trial
You may not qualify if:
- Pregnancy
- Lactation: currently breastfeeding
- Taken clopidogrel within 7 days
- Taken warfarin within 5 days
- Had full therapeutic dose unfractionated heparin within 6 hours
- Had full therapeutic dose low molecular weight heparin (LMWH) within 12 hours
- Known clotting disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Westmead Hospital
Westmead, New South Wales, 2145, Australia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Bourke
Westmead Hospital - Endoscopy Unit
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Dr Michael Bourke
Study Record Dates
First Submitted
June 9, 2011
First Posted
June 14, 2011
Study Start
June 3, 2019
Primary Completion
June 3, 2019
Study Completion
June 3, 2019
Last Updated
March 27, 2025
Record last verified: 2025-03